Takeda Pharmaceutical Company Limited
Recent events
Recent events tied to this brand in public sources.
Back to profile7 entries
2026
Takeda launches Orzeyful
Takeda Pharmaceutical has fully launched Orzeyful, a narcolepsy treatment that targets the root cause rather than addressing only symptoms.
2021
United Airlines announces Eco-Skies Alliance sustainable fuel plan
United Airlines said it had partnered with global firms in an Eco-Skies Alliance to finance the use this year of about 3.4 million gallons of low-carbon sustainable aviation fuel derived from trash.
2021
BridGene and Takeda announce research collaboration
BridGene Biosciences announced a strategic research collaboration and licensing agreement with Takeda to establish up to five drug discovery programs. BridGene is eligible for potential milestone payments and royalties, while Takeda may receive exclusive licenses for selected validated targets.
2021
Anima Biotech and Takeda announce drug-discovery collaboration
Anima Biotech announced a strategic collaboration with Takeda to discover and develop medicines for genetically defined neurological diseases. Takeda holds exclusive rights to develop and commercialise the molecules, and the parties will collaborate to advance them.
2021
PatientsLikeMe and Takeda announce strategic partnership
PatientsLikeMe announced a strategic partnership with Takeda to enhance its digital platform and gather insights on patient experience and unmet needs, initially focusing on rare diseases, immunology, neuroscience and mental health, and gastroenterology.
2020
Presage and Takeda announce expanded research collaboration
Presage Biosciences announced a new research collaboration with Takeda to use CIVO in Phase 0 trials evaluating multiple investigational oncology agents and combinations.
2019
Takeda signs exclusive global license for TAK-101
Takeda signed a deal with COUR Pharmaceutical Development for an exclusive global license to develop and commercialize TAK-101, with COUR eligible for future payments and royalties on sales of commercialized products.